Palliation of allograft vasculopathy with transluminal angioplasty

Angioplasty versus stenting for cardiac allograft vasculopathy

Transluminal Angioplasty

196 4 Dotter directed catheter-mediated therapy -=..;:,nic occlusive disease by em ploying coaXia l -,,,,,,..,"t:'j. These initial proced ures were performed in a:.......,; _raphic sui re (2). The li mitations o f coaxial _""" dilatation were recognized early by Dotter, ;. him to investigate other dilatatlon methods. In c..~Pt to improve the dilatation techni que, in urdized a Fogarty balloon c...

Allograft Vasculopathy

Ma Cardiac allograft vasculopathy (CAV) remains the Achilles’ heel of long-term survival after heart transplantation. Almost one-third of patients develop CAV by 5 years post-transplant and 1 in 8 deaths beyond a year are due to CAV. Abnormal vascular fibroproliferation in CAV occurs as a result of coronary endothelial inflammation, injury, and dysfunction triggered by immune and nonimmune insu...

Percutaneous transluminal coronary angioplasty.

Percutaneous transluminal coronary angioplasty (PTCA) is a nonoperative mechanical dilatation of atherosclerotic coronary artery stenosis by a balloon-tipped dilating catheter system. This method can effectively reduce highly stenotic coronary lesions and provide early recovery of ischemic but viable myocardium. The technique of transluminal angioplasty was originally devised by Dotter and Judk...

Conventional angioplasty versus percutaneous transluminal laser angioplasty.